4//SEC Filing
Sandler Alan B. 4
Accession 0001214659-22-013305
CIK 0001576263other
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 6:00 PM ET
Size
7.2 KB
Accession
0001214659-22-013305
Insider Transaction Report
Form 4
Sandler Alan B.
Chief Medical Officer
Transactions
- Award
Common Stock
2022-11-07+40,000→ 40,000 total - Award
Stock Option (Right to buy)
2022-11-07+65,000→ 65,000 totalExercise: $0.00Exp: 2032-11-06→ Common Stock (65,000 underlying)
Footnotes (2)
- [F1]This represents a Restricted Stock Unit grant with a vesting period of 4 years that vests 25% annually from grant date and subject to the reporting persons continuously service to the issuer.
- [F2]25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested.
Documents
Issuer
Mirati Therapeutics, Inc.
CIK 0001576263
Entity typeother
Related Parties
1- filerCIK 0001835966
Filing Metadata
- Form type
- 4
- Filed
- Nov 7, 7:00 PM ET
- Accepted
- Nov 8, 6:00 PM ET
- Size
- 7.2 KB